Please assess the completion status of the following clinical trial:

Trial Title: A Prospective, Multicenter, Single Arm Feasibility Study of the Safety and Performance of GRADION™ Hip Total Cartilage Replacement (TCR)™ in the Treatment of Degenerative Joint Disease of the Hip

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Primary hip surgery for Noninflammatory Degenerative Joint Disease (NIDJD) such as osteo/degenerative arthritis, and is indicated for cartilage replacement~* Skeletally mature or at least 18 years of age and has normal anatomy~* Patient signs the Informed Consent form~* Failed medical management~* There will be size limitations on patients also - available size range is 46mm-54mm.~Exclusion Criteria:~* Allergic to polyether urethane, sodium polyacrylate, bone cement or any of its components~* Previous fusion, acute femoral neck fracture and/or above knee amputation~* Revision of any previous hip procedure~* Slipped capital femoral epiphysis (SCFE)~* Rheumatoid arthritis~* AVN

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GRADION™ Hip Total Cartilage Replacement (TCR)™ (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).